Literature DB >> 31454099

ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.

Fei Li1,2, Zhong Deng3, Ling Zhang2,4, Caizhi Wu2, Ying Jin2, Inah Hwang5, Olga Vladimirova3, Libo Xu2,4, Lynnie Yang2, Bin Lu2, Javaraju Dheekollu3, Jian-Yi Li6, Hua Feng1, Jian Hu7, Christopher R Vakoc2, Haoqiang Ying8, Jihye Paik5, Paul M Lieberman3, Hongwu Zheng2,5.   

Abstract

Loss of the histone H3.3-specific chaperone component ATRX or its partner DAXX frequently occurs in human cancers that employ alternative lengthening of telomeres (ALT) for chromosomal end protection, yet the underlying mechanism remains unclear. Here, we report that ATRX/DAXX does not serve as an immediate repressive switch for ALT. Instead, ATRX or DAXX depletion gradually induces telomere DNA replication dysfunction that activates not only homology-directed DNA repair responses but also cell cycle checkpoint control. Mechanistically, we demonstrate that this process is contingent on ATRX/DAXX histone chaperone function, independently of telomere length. Combined ATAC-seq and telomere chromatin immunoprecipitation studies reveal that ATRX loss provokes progressive telomere decondensation that culminates in the inception of persistent telomere replication dysfunction. We further show that endogenous telomerase activity cannot overcome telomere dysfunction induced by ATRX loss, leaving telomere repair-based ALT as the only viable mechanism for telomere maintenance during immortalization. Together, these findings implicate ALT activation as an adaptive response to ATRX/DAXX loss-induced telomere replication dysfunction.
© 2019 The Authors.

Entities:  

Keywords:  zzm321990ALTzzm321990; ATRX/DAXX; DNA damage; immortalization; telomere

Mesh:

Substances:

Year:  2019        PMID: 31454099      PMCID: PMC6769380          DOI: 10.15252/embj.201796659

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   14.012


  87 in total

Review 1.  Beginning to understand the end of the chromosome.

Authors:  Thomas R Cech
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.

Authors:  Pascal Drané; Khalid Ouararhni; Arnaud Depaux; Muhammad Shuaib; Ali Hamiche
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

3.  The RCAF complex mediates chromatin assembly during DNA replication and repair.

Authors:  J K Tyler; C R Adams; S R Chen; R Kobayashi; R T Kamakaka; J T Kadonaga
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops.

Authors:  W I Sundquist; A Klug
Journal:  Nature       Date:  1989-12-14       Impact factor: 49.962

5.  Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).

Authors:  R J Gibbons; D J Picketts; L Villard; D R Higgs
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

Review 6.  Molecular basis of telomere dysfunction in human genetic diseases.

Authors:  Grzegorz Sarek; Paulina Marzec; Pol Margalef; Simon J Boulton
Journal:  Nat Struct Mol Biol       Date:  2015-11       Impact factor: 15.369

7.  ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.

Authors:  Martin J Law; Karen M Lower; Hsiao P J Voon; Jim R Hughes; David Garrick; Vip Viprakasit; Matthew Mitson; Marco De Gobbi; Marco Marra; Andrew Morris; Aaron Abbott; Steven P Wilder; Stephen Taylor; Guilherme M Santos; Joe Cross; Helena Ayyub; Steven Jones; Jiannis Ragoussis; Daniela Rhodes; Ian Dunham; Douglas R Higgs; Richard J Gibbons
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

8.  ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes.

Authors:  Hsiao P J Voon; Jim R Hughes; Christina Rode; Inti A De La Rosa-Velázquez; Thomas Jenuwein; Robert Feil; Douglas R Higgs; Richard J Gibbons
Journal:  Cell Rep       Date:  2015-04-09       Impact factor: 9.423

9.  The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.

Authors:  Gang Wu; Alexander K Diaz; Barbara S Paugh; Sherri L Rankin; Bensheng Ju; Yongjin Li; Xiaoyan Zhu; Chunxu Qu; Xiang Chen; Junyuan Zhang; John Easton; Michael Edmonson; Xiaotu Ma; Charles Lu; Panduka Nagahawatte; Erin Hedlund; Michael Rusch; Stanley Pounds; Tong Lin; Arzu Onar-Thomas; Robert Huether; Richard Kriwacki; Matthew Parker; Pankaj Gupta; Jared Becksfort; Lei Wei; Heather L Mulder; Kristy Boggs; Bhavin Vadodaria; Donald Yergeau; Jake C Russell; Kerri Ochoa; Robert S Fulton; Lucinda L Fulton; Chris Jones; Frederick A Boop; Alberto Broniscer; Cynthia Wetmore; Amar Gajjar; Li Ding; Elaine R Mardis; Richard K Wilson; Michael R Taylor; James R Downing; David W Ellison; Jinghui Zhang; Suzanne J Baker
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

10.  ATRX is a regulator of therapy induced senescence in human cells.

Authors:  Marta Kovatcheva; Will Liao; Mary E Klein; Nicolas Robine; Heather Geiger; Aimee M Crago; Mark A Dickson; William D Tap; Samuel Singer; Andrew Koff
Journal:  Nat Commun       Date:  2017-08-30       Impact factor: 14.919

View more
  26 in total

1.  Inhibition of SETMAR-H3K36me2-NHEJ repair axis in residual disease cells prevents glioblastoma recurrence.

Authors:  Ekjot Kaur; Jyothi Nair; Atanu Ghorai; Saket V Mishra; Anagha Achareker; Madhura Ketkar; Debashmita Sarkar; Sameer Salunkhe; Jacinth Rajendra; Nilesh Gardi; Sanket Desai; Prajish Iyer; Rahul Thorat; Amit Dutt; Aliasgar Moiyadi; Shilpee Dutt
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

2.  A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.

Authors:  Shiman Wu; Xi Zhang; Wenting Rui; Yaru Sheng; Yang Yu; Yong Zhang; Zhenwei Yao; Tianming Qiu; Yan Ren
Journal:  Eur Radiol       Date:  2022-02-08       Impact factor: 5.315

Review 3.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

Review 4.  Hallmarks of DNA replication stress.

Authors:  Sneha Saxena; Lee Zou
Journal:  Mol Cell       Date:  2022-06-16       Impact factor: 19.328

5.  Identifying biomarkers associated with tumor growth rate: a longitudinal preoperative magnetic resonance imaging follow-up of low-grade gliomas.

Authors:  Yukun Liu; Ziwen Fan; Shaowu Li; Xing Liu; Tao Jiang; Yinyan Wang; Lei Wang
Journal:  Ann Transl Med       Date:  2022-06

Review 6.  Telomere fusions and translocations: a bridge too far?

Authors:  Susanna Stroik; Eric A Hendrickson
Journal:  Curr Opin Genet Dev       Date:  2020-03-13       Impact factor: 5.578

Review 7.  Communication between chromatin and homologous recombination.

Authors:  Priyanka Verma; Roger A Greenberg
Journal:  Curr Opin Genet Dev       Date:  2021-06-05       Impact factor: 5.578

8.  Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells.

Authors:  Thomas Aschacher; Brigitte Wolf; Olivia Aschacher; Florian Enzmann; Viktoria Laszlo; Barbara Messner; Adrian Türkcan; Serge Weis; Sabine Spiegl-Kreinecker; Klaus Holzmann; Günther Laufer; Marek Ehrlich; Michael Bergmann
Journal:  Neoplasia       Date:  2019-12-14       Impact factor: 5.715

9.  Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres.

Authors:  Sandra Segura-Bayona; Marina Villamor-Payà; Camille Stephan-Otto Attolini; Lars M Koenig; Maria Sanchiz-Calvo; Simon J Boulton; Travis H Stracker
Journal:  Cell Rep       Date:  2020-08-04       Impact factor: 9.423

Review 10.  Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.

Authors:  S L George; V Parmar; F Lorenzi; L V Marshall; Y Jamin; E Poon; P Angelini; L Chesler
Journal:  J Exp Clin Cancer Res       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.